Open-loop glucose control: Automatic IOB-based super-bolus feature for commercial insulin pumps

BACKGROUND AND OBJECTIVE Although there has been significant progress towards closed-loop type 1 diabetes mellitus (T1DM) treatments, most diabetic patients still treat this metabolic disorder in an open-loop manner, based on insulin pump therapy (basal and bolus insulin infusion). This paper presents a method for automatic insulin bolus shaping based on insulin-on-board (IOB) as an alternative to conventional bolus dosing. METHODS The methodology presented allows the pump to generate the so-called super-bolus (SB) employing a two-compartment IOB dynamic model. The extra amount of insulin to boost the bolus and the basal cutoff time are computed using the duration of insulin action (DIA). In this way, the pump automatically re-establishes basal insulin when IOB reaches its basal level. Thus, detrimental transients caused by manual or a-priori computations are avoided. RESULTS The potential of this method is illustrated via in-silico trials over a 30 patients cohort in single meal and single day scenarios. In the first ones, improvements were found (standard treatment vs. automatic SB) both in percentage time in euglycemia (75g meal: 81.9 ± 15.59 vs. 89.51 ± 11.95, ρ ≃ 0; 100g meal: 75.12 ± 18.23 vs. 85.46 ± 14.96, ρ ≃ 0) and time in hypoglecymia (75g meal: 5.92 ± 14.48 vs. 0.97 ± 4.15, ρ=0.008; 100g meal: 9.5 ± 17.02 vs. 1.85 ± 7.05, ρ=0.014). In a single day scenario, considering intra-patient variability, the time in hypoglycemia was reduced (9.57 ± 14.48 vs. 4.21 ± 6.18, ρ=0.028) and improved the time in euglycemia (79.46 ± 17.46 vs. 86.29 ± 11.73, ρ=0.007). CONCLUSIONS The automatic IOB-based SB has the potential of a better performance in comparison with the standard treatment, particularly for high glycemic index meals with high carbohydrate content. Both glucose excursion and time spent in hypoglycemia were reduced.

[1]  Ali Cinar,et al.  Plasma Insulin Estimation in People with Type 1 Diabetes Mellitus , 2017 .

[2]  Mauro Boronat,et al.  Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump , 2015, Endocrinology, diabetes & metabolism case reports.

[3]  Roman Hovorka,et al.  Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes , 2010, Journal of diabetes science and technology.

[4]  Malgorzata E. Wilinska,et al.  Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin , 2005, IEEE Transactions on Biomedical Engineering.

[5]  Beatriz Ricarte,et al.  Real-time estimation of plasma insulin concentration from continuous glucose monitor measurements , 2016, Computer methods in biomechanics and biomedical engineering.

[6]  L. Magni,et al.  Evaluating the Efficacy of Closed-Loop Glucose Regulation via Control-Variability Grid Analysis , 2008, Journal of diabetes science and technology.

[7]  John Walsh,et al.  Confusion Regarding Duration of Insulin Action , 2014, Journal of diabetes science and technology.

[8]  Claudio Cobelli,et al.  Circadian variability of insulin sensitivity: physiological input for in silico artificial pancreas. , 2015, Diabetes technology & therapeutics.

[9]  Christofer Toumazou,et al.  Method for automatic adjustment of an insulin bolus calculator: In silico robustness evaluation under intra-day variability , 2015, Comput. Methods Programs Biomed..

[10]  Niels Kjølstad Poulsen,et al.  An Adaptive Nonlinear Basal-Bolus Calculator for Patients With Type 1 Diabetes , 2017, Journal of diabetes science and technology.

[11]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[12]  Christofer Toumazou,et al.  Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability , 2017, Comput. Methods Programs Biomed..

[13]  Jorge Bondia,et al.  Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial. , 2012, Diabetes technology & therapeutics.

[14]  Claudio Cobelli,et al.  Meal Simulation Model of the Glucose-Insulin System , 2007, IEEE Transactions on Biomedical Engineering.

[15]  Claudio Cobelli,et al.  One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator , 2016, IEEE Transactions on Biomedical Engineering.

[16]  Graham C. Goodwin,et al.  A fundamental control limitation for linear positive systems with application to Type 1 diabetes treatment , 2015, Autom..

[17]  Fabian León-Vargas,et al.  Postprandial blood glucose control using a hybrid adaptive PD controller with insulin-on-board limitation , 2013, Biomed. Signal Process. Control..

[18]  Howard C. Zisser,et al.  Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report , 2016, Diabetes Care.

[19]  Claudio Cobelli,et al.  Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results , 2018, IEEE Transactions on Biomedical Engineering.

[20]  Christofer Toumazou,et al.  A Simple Robust Method for Estimating the Glucose Rate of Appearance from Mixed Meals , 2012, Journal of diabetes science and technology.

[21]  Claudio Cobelli,et al.  Models of subcutaneous insulin kinetics. A critical review , 2000, Comput. Methods Programs Biomed..

[22]  Josep Vehí,et al.  Combining Basal-Bolus Insulin Infusion for Tight Postprandial Glucose Control: An in Silico Evaluation in Adults, Children, and Adolescents , 2010, Journal of diabetes science and technology.

[23]  Ahmad Haidar,et al.  Pharmacokinetics of Insulin Aspart in Pump-Treated Subjects With Type 1 Diabetes: Reproducibility and Effect of Age, Weight, and Duration of Diabetes , 2013, Diabetes Care.

[24]  Eyal Dassau,et al.  Bolus calculator: a review of four "smart" insulin pumps. , 2008, Diabetes technology & therapeutics.